<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20230820000919&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.17.9.post6+86293ac&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;ff=20230820000919&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.17.9.post6+86293ac)</generator>
<language>en</language>
<lastbuilddate>Sun, 20 Aug 2023 04:09:20 +0000</lastbuilddate>
<pubDate>Sat, 19 Aug 2023 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Plaque morphology, inflammation, and outcome: cautious and tempered interpretation warranted</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37596979/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 19:ehad527. doi: 10.1093/eurheartj/ehad527. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37596979/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37596979</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad527>10.1093/eurheartj/ehad527</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37596979</guid>
<pubDate>Sat, 19 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Steven E Nissen</dc:creator>
<dc:date>2023-08-19</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Plaque morphology, inflammation, and outcome: cautious and tempered interpretation warranted</dc:title>
<dc:identifier>pmid:37596979</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad527</dc:identifier>
</item>
<item>
<title>Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595566/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>Mucosal-associated invariant T (MAIT) cells represent an abundant innate-like T cell subtype in the human liver. MAIT cells are assigned crucial roles in regulating immunity and inflammation, yet their role in liver cancer remains elusive. Here, we present a MAIT cell-centered profiling of hepatocellular carcinoma (HCC) using scRNA-seq, flow cytometry, and co-detection by indexing (CODEX) imaging of paired patient samples. These analyses highlight the heterogeneity and dysfunctionality of MAIT...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3686-3705.e32. doi: 10.1016/j.cell.2023.07.026.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Mucosal-associated invariant T (MAIT) cells represent an abundant innate-like T cell subtype in the human liver. MAIT cells are assigned crucial roles in regulating immunity and inflammation, yet their role in liver cancer remains elusive. Here, we present a MAIT cell-centered profiling of hepatocellular carcinoma (HCC) using scRNA-seq, flow cytometry, and co-detection by indexing (CODEX) imaging of paired patient samples. These analyses highlight the heterogeneity and dysfunctionality of MAIT cells in HCC and their defective capacity to infiltrate liver tumors. Machine-learning tools were used to dissect the spatial cellular interaction network within the MAIT cell neighborhood. Co-localization in the adjacent liver and interaction between niche-occupying CSF1R<sup>+</sup>PD-L1<sup>+</sup> tumor-associated macrophages (TAMs) and MAIT cells was identified as a key regulatory element of MAIT cell dysfunction. Perturbation of this cell-cell interaction in ex vivo co-culture studies using patient samples and murine models reinvigorated MAIT cell cytotoxicity. These studies suggest that aPD-1/aPD-L1 therapies target MAIT cells in HCC patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595566/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595566</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.026>10.1016/j.cell.2023.07.026</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595566</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Benjamin Ruf</dc:creator>
<dc:creator>Matthias Bruhns</dc:creator>
<dc:creator>Sepideh Babaei</dc:creator>
<dc:creator>Noemi Kedei</dc:creator>
<dc:creator>Lichun Ma</dc:creator>
<dc:creator>Mahler Revsine</dc:creator>
<dc:creator>Mohamed-Reda Benmebarek</dc:creator>
<dc:creator>Chi Ma</dc:creator>
<dc:creator>Bernd Heinrich</dc:creator>
<dc:creator>Varun Subramanyam</dc:creator>
<dc:creator>Jonathan Qi</dc:creator>
<dc:creator>Simon Wabitsch</dc:creator>
<dc:creator>Benjamin L Green</dc:creator>
<dc:creator>Kylynda C Bauer</dc:creator>
<dc:creator>Yuta Myojin</dc:creator>
<dc:creator>Layla T Greten</dc:creator>
<dc:creator>Justin D McCallen</dc:creator>
<dc:creator>Patrick Huang</dc:creator>
<dc:creator>Rajiv Trehan</dc:creator>
<dc:creator>Xin Wang</dc:creator>
<dc:creator>Amran Nur</dc:creator>
<dc:creator>Dana Qiang Murphy Soika</dc:creator>
<dc:creator>Marie Pouzolles</dc:creator>
<dc:creator>Christine N Evans</dc:creator>
<dc:creator>Raj Chari</dc:creator>
<dc:creator>David E Kleiner</dc:creator>
<dc:creator>William Telford</dc:creator>
<dc:creator>Kimia Dadkhah</dc:creator>
<dc:creator>Allison Ruchinskas</dc:creator>
<dc:creator>Merrill K Stovroff</dc:creator>
<dc:creator>Jiman Kang</dc:creator>
<dc:creator>Kesha Oza</dc:creator>
<dc:creator>Mathuros Ruchirawat</dc:creator>
<dc:creator>Alexander Kroemer</dc:creator>
<dc:creator>Xin Wei Wang</dc:creator>
<dc:creator>Manfred Claassen</dc:creator>
<dc:creator>Firouzeh Korangy</dc:creator>
<dc:creator>Tim F Greten</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Tumor-associated macrophages trigger MAIT cell dysfunction at the HCC invasive margin</dc:title>
<dc:identifier>pmid:37595566</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.026</dc:identifier>
</item>
<item>
<title>A conserved family of immune effectors cleaves cellular ATP upon viral infection</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595565/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>During viral infection, cells can deploy immune strategies that deprive viruses of molecules essential for their replication. Here, we report a family of immune effectors in bacteria that, upon phage infection, degrade cellular adenosine triphosphate (ATP) and deoxyadenosine triphosphate (dATP) by cleaving the N-glycosidic bond between the adenine and sugar moieties. These ATP nucleosidase effectors are widely distributed within multiple bacterial defense systems, including cyclic...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3619-3631.e13. doi: 10.1016/j.cell.2023.07.020.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">During viral infection, cells can deploy immune strategies that deprive viruses of molecules essential for their replication. Here, we report a family of immune effectors in bacteria that, upon phage infection, degrade cellular adenosine triphosphate (ATP) and deoxyadenosine triphosphate (dATP) by cleaving the N-glycosidic bond between the adenine and sugar moieties. These ATP nucleosidase effectors are widely distributed within multiple bacterial defense systems, including cyclic oligonucleotide-based antiviral signaling systems (CBASS), prokaryotic argonautes, and nucleotide-binding leucine-rich repeat (NLR)-like proteins, and we show that ATP and dATP degradation during infection halts phage propagation. By analyzing homologs of the immune ATP nucleosidase domain, we discover and characterize Detocs, a family of bacterial defense systems with a two-component phosphotransfer-signaling architecture. The immune ATP nucleosidase domain is also encoded within diverse eukaryotic proteins with immune-like architectures, and we show biochemically that eukaryotic homologs preserve the ATP nucleosidase activity. Our findings suggest that ATP and dATP degradation is a cell-autonomous innate immune strategy conserved across the tree of life.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595565/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595565</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.020>10.1016/j.cell.2023.07.020</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595565</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Francois Rousset</dc:creator>
<dc:creator>Erez Yirmiya</dc:creator>
<dc:creator>Shahar Nesher</dc:creator>
<dc:creator>Alexander Brandis</dc:creator>
<dc:creator>Tevie Mehlman</dc:creator>
<dc:creator>Maxim Itkin</dc:creator>
<dc:creator>Sergey Malitsky</dc:creator>
<dc:creator>Adi Millman</dc:creator>
<dc:creator>Sarah Melamed</dc:creator>
<dc:creator>Rotem Sorek</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>A conserved family of immune effectors cleaves cellular ATP upon viral infection</dc:title>
<dc:identifier>pmid:37595565</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.020</dc:identifier>
</item>
<item>
<title>An ethical framework for human embryology with embryo models</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595564/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>A human embryo's legal definition and its entitlement to protection vary greatly worldwide. Recently, human pluripotent stem cells have been used to form in vitro models of early embryos that have challenged legal definitions and raised questions regarding their usage. In this light, we propose a refined legal definition of an embryo, suggest "tipping points" for when human embryo models could eventually be afforded similar protection to that of embryos, and then revisit basic ethical principles...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3548-3557. doi: 10.1016/j.cell.2023.07.028.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">A human embryo's legal definition and its entitlement to protection vary greatly worldwide. Recently, human pluripotent stem cells have been used to form in vitro models of early embryos that have challenged legal definitions and raised questions regarding their usage. In this light, we propose a refined legal definition of an embryo, suggest "tipping points" for when human embryo models could eventually be afforded similar protection to that of embryos, and then revisit basic ethical principles that might help to draft a roadmap for the gradual, justified usage of embryo models in a manner that aims to maximize benefits to society.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595564/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595564</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.028>10.1016/j.cell.2023.07.028</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595564</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Nicolas C Rivron</dc:creator>
<dc:creator>Alfonso Martinez Arias</dc:creator>
<dc:creator>Martin F Pera</dc:creator>
<dc:creator>Naomi Moris</dc:creator>
<dc:creator>Hafez Ismaili M'hamdi</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>An ethical framework for human embryology with embryo models</dc:title>
<dc:identifier>pmid:37595564</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.028</dc:identifier>
</item>
<item>
<title>Insights and strategies for improving equity in graduate school admissions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595563/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>Applying to graduate school can be particularly challenging for students from historically minoritized backgrounds due to a hidden curriculum in the graduate admissions process. To address this issue, a team of volunteer STEM trainees established the Científico Latino Graduate Student Mentorship Initiative (CL-GSMI) in 2019 to support applicants from historically minoritized backgrounds. CL-GSMI is designed to improve access to critical resources, including information, mentorship, and financial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3529-3547. doi: 10.1016/j.cell.2023.07.029.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Applying to graduate school can be particularly challenging for students from historically minoritized backgrounds due to a hidden curriculum in the graduate admissions process. To address this issue, a team of volunteer STEM trainees established the Científico Latino Graduate Student Mentorship Initiative (CL-GSMI) in 2019 to support applicants from historically minoritized backgrounds. CL-GSMI is designed to improve access to critical resources, including information, mentorship, and financial support, and has assisted 443 students in applying and matriculating to graduate school. Using program evaluation data from 2020 to 2021, we highlight areas in graduate school admissions that can be improved to promote equity and inclusion.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595563/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595563</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.029>10.1016/j.cell.2023.07.029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595563</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Melissa Andrea Cadena</dc:creator>
<dc:creator>Cathy Amaya</dc:creator>
<dc:creator>Daisy Duan</dc:creator>
<dc:creator>Carlos Alberto Rico</dc:creator>
<dc:creator>Leonor García-Bayona</dc:creator>
<dc:creator>Aníbal Tornes Blanco</dc:creator>
<dc:creator>Yessica Santana Agreda</dc:creator>
<dc:creator>Gonzalo Javier Villegas Rodríguez</dc:creator>
<dc:creator>Alexis Ceja</dc:creator>
<dc:creator>Vianna G Martinez</dc:creator>
<dc:creator>Olivia V Goldman</dc:creator>
<dc:creator>Robert W Fernandez</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Insights and strategies for improving equity in graduate school admissions</dc:title>
<dc:identifier>pmid:37595563</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.029</dc:identifier>
</item>
<item>
<title>RNA "COURIERs": Enabling synthetic cell-to-cell communication in human cells</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595562/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>The development of molecular couriers to selectively package, export, and recover RNA molecules within human cells is a significant challenge. In this issue of Cell, Horns et al.¹ introduce cellular RNA exporters, termed COURIERs, that package, secrete, and protect RNA cargo and establish the foundation for sophisticated cell-to-cell RNA communication.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3526-3528. doi: 10.1016/j.cell.2023.07.030.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The development of molecular couriers to selectively package, export, and recover RNA molecules within human cells is a significant challenge. In this issue of Cell, Horns et al.<sup>1</sup> introduce cellular RNA exporters, termed COURIERs, that package, secrete, and protect RNA cargo and establish the foundation for sophisticated cell-to-cell RNA communication.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595562/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595562</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.030>10.1016/j.cell.2023.07.030</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595562</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Taek Kang</dc:creator>
<dc:creator>Leonidas Bleris</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>RNA "COURIERs": Enabling synthetic cell-to-cell communication in human cells</dc:title>
<dc:identifier>pmid:37595562</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.030</dc:identifier>
</item>
<item>
<title>The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595561/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>Channels connecting the skull bone marrow and the meninges have recently been discovered as a path for immune cell and molecule trafficking. In this issue of Cell, Kolabas, Kuemmerle, Perneczky, Förstera, and colleagues characterize these channels in humans and mice, revealing unique features of skull bone marrow and localized activation in human pathology.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3524-3526. doi: 10.1016/j.cell.2023.07.025.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Channels connecting the skull bone marrow and the meninges have recently been discovered as a path for immune cell and molecule trafficking. In this issue of Cell, Kolabas, Kuemmerle, Perneczky, Förstera, and colleagues characterize these channels in humans and mice, revealing unique features of skull bone marrow and localized activation in human pathology.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595561/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595561</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.025>10.1016/j.cell.2023.07.025</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595561</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Sachin P Gadani</dc:creator>
<dc:creator>Peter A Calabresi</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The calvaria stands alone: Unique aspects of the skull bone marrow-meninges border</dc:title>
<dc:identifier>pmid:37595561</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.025</dc:identifier>
</item>
<item>
<title>Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37595560/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>The FDA has recently approved Krystal biotech's beremagene geperpavec (B-VEC, Vyjuvek) to treat the wounds of dystrophic epidermolysis bullosa (DEB) patients. This represents a giant step, not only toward the treatment of this devastating disease, but also for the whole field of non-replicative (nr) recombinant HSV-1 vectors for gene therapy. To view this Bench to Bedside, open or download the PDF.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 17;186(17):3523-3523.e1. doi: 10.1016/j.cell.2023.07.031.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The FDA has recently approved Krystal biotech's beremagene geperpavec (B-VEC, Vyjuvek) to treat the wounds of dystrophic epidermolysis bullosa (DEB) patients. This represents a giant step, not only toward the treatment of this devastating disease, but also for the whole field of non-replicative (nr) recombinant HSV-1 vectors for gene therapy. To view this Bench to Bedside, open or download the PDF.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37595560/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37595560</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.031>10.1016/j.cell.2023.07.031</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37595560</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alberto L Epstein</dc:creator>
<dc:creator>Cornelia Haag-Molkenteller</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Herpes simplex virus gene therapy for dystrophic epidermolysis bullosa (DEB)</dc:title>
<dc:identifier>pmid:37595560</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.031</dc:identifier>
</item>
<item>
<title>JAMA Network Call for Papers on Health and the 2024 US Election</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37594888/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2023 Aug 18. doi: 10.1001/jamacardio.2023.2857. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37594888/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37594888</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2023.2857>10.1001/jamacardio.2023.2857</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37594888</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alison Galbraith</dc:creator>
<dc:creator>Annette Flanagin</dc:creator>
<dc:creator>Aaron E Carroll</dc:creator>
<dc:creator>John Z Ayanian</dc:creator>
<dc:creator>Robert O Bonow</dc:creator>
<dc:creator>Neil Bressler</dc:creator>
<dc:creator>Dimitri Christakis</dc:creator>
<dc:creator>Mary L Nora Disis</dc:creator>
<dc:creator>Sharon K Inouye</dc:creator>
<dc:creator>Andrew Josephson</dc:creator>
<dc:creator>Dost Öngür</dc:creator>
<dc:creator>Jay F Piccirillo</dc:creator>
<dc:creator>Kanade Shinkai</dc:creator>
<dc:creator>Kirsten Bibbins-Domingo</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>JAMA Network Call for Papers on Health and the 2024 US Election</dc:title>
<dc:identifier>pmid:37594888</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2023.2857</dc:identifier>
</item>
<item>
<title>Optical Control of Cardiac Rhythm by In Vivo Photoactivation of an ERG Channel Peptide Inhibitor</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37593901/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18. doi: 10.1161/CIRCRESAHA.123.322880. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37593901/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37593901</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.322880>10.1161/CIRCRESAHA.123.322880</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37593901</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Jérôme Montnach</dc:creator>
<dc:creator>Hugo Millet</dc:creator>
<dc:creator>Antoine Persello</dc:creator>
<dc:creator>Hervé Meudal</dc:creator>
<dc:creator>Stephan De Waard</dc:creator>
<dc:creator>Pietro Mesrica</dc:creator>
<dc:creator>Barbara Ribeiro</dc:creator>
<dc:creator>Jérémie Richard</dc:creator>
<dc:creator>Agnès Hivonnait</dc:creator>
<dc:creator>Agnès Tessier</dc:creator>
<dc:creator>Benjamin Lauzier</dc:creator>
<dc:creator>Flavien Charpentier</dc:creator>
<dc:creator>Matteo E Mangoni</dc:creator>
<dc:creator>Céline Landon</dc:creator>
<dc:creator>Chris Jopling</dc:creator>
<dc:creator>Michel De Waard</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Optical Control of Cardiac Rhythm by In Vivo Photoactivation of an ERG Channel Peptide Inhibitor</dc:title>
<dc:identifier>pmid:37593901</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.322880</dc:identifier>
</item>
<item>
<title>Physical activity patterns and cardiovascular health: 'yes, weekend!'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592862/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad520. doi: 10.1093/eurheartj/ehad520. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592862/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37592862</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad520>10.1093/eurheartj/ehad520</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592862</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Rocco Vergallo</dc:creator>
<dc:creator>Leonarda Galiuto</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Physical activity patterns and cardiovascular health: 'yes, weekend!'</dc:title>
<dc:identifier>pmid:37592862</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad520</dc:identifier>
</item>
<item>
<title>Ready for rapid rule-out of acute myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592857/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad519. doi: 10.1093/eurheartj/ehad519. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592857/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37592857</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad519>10.1093/eurheartj/ehad519</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592857</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Goaris W A Aarts</dc:creator>
<dc:creator>Cyril Camaro</dc:creator>
<dc:creator>Niels van Royen</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Ready for rapid rule-out of acute myocardial infarction</dc:title>
<dc:identifier>pmid:37592857</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad519</dc:identifier>
</item>
<item>
<title>End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592821/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad511. doi: 10.1093/eurheartj/ehad511. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: For patients with congenitally corrected transposition of the great arteries (ccTGA), factors associated with progression to end-stage congestive heart failure (CHF) remain largely unclear.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: This multicentre, retrospective cohort study included adults with ccTGA seen at a congenital heart disease centre. Clinical data from initial and most recent visits were obtained. The composite primary outcome was mechanical circulatory support, heart transplantation, or death.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: From 558 patients (48% female, age at first visit 36 ± 14.2 years, median follow-up 8.7 years), the event rate of the primary outcome was 15.4 per 1000 person-years (11 mechanical circulatory support implantations, 12 transplantations, and 52 deaths). Patients experiencing the primary outcome were older and more likely to have a history of atrial arrhythmia. The primary outcome was highest in those with both moderate/severe right ventricular (RV) dysfunction and tricuspid regurgitation (n = 110, 31 events) and uncommon in those with mild/less RV dysfunction and tricuspid regurgitation (n = 181, 13 events, P &lt; .001). Outcomes were not different based on anatomic complexity and history of tricuspid valve surgery or of subpulmonic obstruction. New CHF admission or ventricular arrhythmia was associated with the primary outcome. Individuals who underwent childhood surgery had more adverse outcomes than age- and sex-matched controls. Multivariable Cox regression analysis identified older age, prior CHF admission, and severe RV dysfunction as independent predictors for the primary outcome.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Patients with ccTGA have variable deterioration to end-stage heart failure or death over time, commonly between their fifth and sixth decades. Predictors include arrhythmic and CHF events and severe RV dysfunction but not anatomy or need for tricuspid valve surgery.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592821/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37592821</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad511>10.1093/eurheartj/ehad511</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592821</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Alexandra C van Dissel</dc:creator>
<dc:creator>Alexander R Opotowsky</dc:creator>
<dc:creator>Luke J Burchill</dc:creator>
<dc:creator>Jamil Aboulhosn</dc:creator>
<dc:creator>Jasmine Grewal</dc:creator>
<dc:creator>Adam M Lubert</dc:creator>
<dc:creator>Petra Antonova</dc:creator>
<dc:creator>Sangeeta Shah</dc:creator>
<dc:creator>Timothy Cotts</dc:creator>
<dc:creator>Anitha S John</dc:creator>
<dc:creator>William Aaron Kay</dc:creator>
<dc:creator>Christopher DeZorzi</dc:creator>
<dc:creator>Anthony Magalski</dc:creator>
<dc:creator>Frank Han</dc:creator>
<dc:creator>David Baker</dc:creator>
<dc:creator>Joseph Kay</dc:creator>
<dc:creator>Elizabeth Yeung</dc:creator>
<dc:creator>Isabelle Vonder Muhll</dc:creator>
<dc:creator>Stephen Pylypchuk</dc:creator>
<dc:creator>Marissa C Kuo</dc:creator>
<dc:creator>Jeremy Nicolarsen</dc:creator>
<dc:creator>Berardo Sarubbi</dc:creator>
<dc:creator>Flavia Fusco</dc:creator>
<dc:creator>Susan M Jameson</dc:creator>
<dc:creator>Jonathan Cramer</dc:creator>
<dc:creator>Tripti Gupta</dc:creator>
<dc:creator>Pastora Gallego</dc:creator>
<dc:creator>Clare O'Donnell</dc:creator>
<dc:creator>Jane Hannah</dc:creator>
<dc:creator>Mikael Dellborg</dc:creator>
<dc:creator>Robert M Kauling</dc:creator>
<dc:creator>Salil Ginde</dc:creator>
<dc:creator>Eric V Krieger</dc:creator>
<dc:creator>Fred Rodriguez</dc:creator>
<dc:creator>Payam Dehghani</dc:creator>
<dc:creator>Shelby Kutty</dc:creator>
<dc:creator>Joshua Wong</dc:creator>
<dc:creator>William M Wilson</dc:creator>
<dc:creator>Carla P Rodriguez-Monserrate</dc:creator>
<dc:creator>Jolien Roos-Hesselink</dc:creator>
<dc:creator>David S Celermajer</dc:creator>
<dc:creator>Paul Khairy</dc:creator>
<dc:creator>Craig S Broberg</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>End-stage heart failure in congenitally corrected transposition of the great arteries: a multicentre study</dc:title>
<dc:identifier>pmid:37592821</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad511</dc:identifier>
</item>
<item>
<title>Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592753/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: Prognosis after LSIE is determined by multiple factors, including vegetation size.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad507. doi: 10.1093/eurheartj/ehad507. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Even though vegetation size in infective endocarditis (IE) has been associated with embolic events (EEs) and mortality risk, it is unclear whether vegetation size associated with these potential outcomes is different in left-sided IE (LSIE). This study aimed to seek assessing the vegetation cut-off size as predictor of EE or 30-day mortality for LSIE and to determine risk predictors of these outcomes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The European Society of Cardiology EURObservational Research Programme European Infective Endocarditis is a prospective, multicentre registry including patients with definite or possible IE throughout 2016-18. Cox multivariable logistic regression analysis was performed to assess variables associated with EE or 30-day mortality.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: There were 2171 patients with LSIE (women 31.5%). Among these affected patients, 459 (21.1%) had a new EE or died in 30 days. The cut-off value of vegetation size for predicting EEs or 30-day mortality was >;10 mm [hazard ratio (HR) 1.38, 95% confidence interval (CI) 1.13-1.69, P = .0015]. Other adjusted predictors of risk of EE or death were as follows: EE on admission (HR 1.89, 95% CI 1.54-2.33, P &lt; .0001), history of heart failure (HR 1.53, 95% CI 1.21-1.93, P = .0004), creatinine >;2 mg/dL (HR 1.59, 95% CI 1.25-2.03, P = .0002), Staphylococcus aureus (HR 1.36, 95% CI 1.08-1.70, P = .008), congestive heart failure (HR 1.40, 95% CI 1.12-1.75, P = .003), presence of haemorrhagic stroke (HR 4.57, 95% CI 3.08-6.79, P &lt; .0001), alcohol abuse (HR 1.45, 95% CI 1.04-2.03, P = .03), presence of cardiogenic shock (HR 2.07, 95% CI 1.29-3.34, P = .003), and not performing left surgery (HR 1.30 95% CI 1.05-1.61, P = .016) (C-statistic = .68).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Prognosis after LSIE is determined by multiple factors, including vegetation size.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592753/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37592753</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad507>10.1093/eurheartj/ehad507</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592753</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Antonia Sambola</dc:creator>
<dc:creator>Jordi Lozano-Torres</dc:creator>
<dc:creator>Eric Boersma</dc:creator>
<dc:creator>Carmen Olmos</dc:creator>
<dc:creator>Julien Ternacle</dc:creator>
<dc:creator>Francisco Calvo</dc:creator>
<dc:creator>Christophe Tribouilloy</dc:creator>
<dc:creator>Vlatka Reskovic-Luksic</dc:creator>
<dc:creator>Jadranka Separovic-Hanzevacki</dc:creator>
<dc:creator>Seung-Woo Park</dc:creator>
<dc:creator>Sebastiaan Bekkers</dc:creator>
<dc:creator>Kwan-Leung Chan</dc:creator>
<dc:creator>Abdallah Almaghraby</dc:creator>
<dc:creator>Bernard Iung</dc:creator>
<dc:creator>Patrizio Lancellotti</dc:creator>
<dc:creator>Gilbert Habib</dc:creator>
<dc:creator>ESC EORP EURO-ENDO Registry Investigator Group</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry</dc:title>
<dc:identifier>pmid:37592753</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad507</dc:identifier>
</item>
<item>
<title>Congenitally corrected transposition of the great arteries: have we shifted the disease 'trajectory?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37592741/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 18:ehad482. doi: 10.1093/eurheartj/ehad482. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37592741/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37592741</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad482>10.1093/eurheartj/ehad482</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37592741</guid>
<pubDate>Fri, 18 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Magalie Ladouceur</dc:creator>
<dc:date>2023-08-18</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Congenitally corrected transposition of the great arteries: have we shifted the disease 'trajectory?</dc:title>
<dc:identifier>pmid:37592741</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad482</dc:identifier>
</item>
<item>
<title>The projection-specific signals that establish functionally segregated dopaminergic synapses</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37591240/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>Dopaminergic projections regulate various brain functions and are implicated in many neuropsychiatric disorders. There are two anatomically and functionally distinct dopaminergic projections connecting the midbrain to striatum: nigrostriatal, which controls movement, and mesolimbic, which regulates motivation. However, how these discrete dopaminergic synaptic connections are established is unknown. Through an unbiased search, we identify that two groups of antagonistic TGF-β family members, bone...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 9:S0092-8674(23)00801-2. doi: 10.1016/j.cell.2023.07.023. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Dopaminergic projections regulate various brain functions and are implicated in many neuropsychiatric disorders. There are two anatomically and functionally distinct dopaminergic projections connecting the midbrain to striatum: nigrostriatal, which controls movement, and mesolimbic, which regulates motivation. However, how these discrete dopaminergic synaptic connections are established is unknown. Through an unbiased search, we identify that two groups of antagonistic TGF-β family members, bone morphogenetic protein (BMP)6/BMP2 and transforming growth factor (TGF)-β2, regulate dopaminergic synapse development of nigrostriatal and mesolimbic neurons, respectively. Projection-preferential expression of their receptors contributes to specific synapse development. Downstream, Smad1 and Smad2 are specifically activated and required for dopaminergic synapse development and function in nigrostriatal vs. mesolimbic projections. Remarkably, Smad1 mutant mice show motor defects, whereas Smad2 mutant mice show lack of motivation. These results uncover the molecular logic underlying the proper establishment of functionally segregated dopaminergic synapses and may provide strategies to treat relevant, projection-specific disease symptoms by targeting specific BMPs/TGF-β and/or Smads.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37591240/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37591240</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.023>10.1016/j.cell.2023.07.023</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37591240</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Akiko Terauchi</dc:creator>
<dc:creator>Patricia Yee</dc:creator>
<dc:creator>Erin M Johnson-Venkatesh</dc:creator>
<dc:creator>Mariel P Seiglie</dc:creator>
<dc:creator>Lisa Kim</dc:creator>
<dc:creator>Julia C Pitino</dc:creator>
<dc:creator>Eli Kritzer</dc:creator>
<dc:creator>Qiyu Zhang</dc:creator>
<dc:creator>Jie Zhou</dc:creator>
<dc:creator>Yulong Li</dc:creator>
<dc:creator>David D Ginty</dc:creator>
<dc:creator>Wei-Chung A Lee</dc:creator>
<dc:creator>Hisashi Umemori</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Cell</dc:source>
<dc:title>The projection-specific signals that establish functionally segregated dopaminergic synapses</dc:title>
<dc:identifier>pmid:37591240</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.023</dc:identifier>
</item>
<item>
<title>Atlas of the aging mouse brain reveals white matter as vulnerable foci</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37591239/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>Aging is the key risk factor for cognitive decline, yet the molecular changes underlying brain aging remain poorly understood. Here, we conducted spatiotemporal RNA sequencing of the mouse brain, profiling 1,076 samples from 15 regions across 7 ages and 2 rejuvenation interventions. Our analysis identified a brain-wide gene signature of aging in glial cells, which exhibited spatially defined changes in magnitude. By integrating spatial and single-nucleus transcriptomics, we found that glial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2023 Aug 8:S0092-8674(23)00805-X. doi: 10.1016/j.cell.2023.07.027. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Aging is the key risk factor for cognitive decline, yet the molecular changes underlying brain aging remain poorly understood. Here, we conducted spatiotemporal RNA sequencing of the mouse brain, profiling 1,076 samples from 15 regions across 7 ages and 2 rejuvenation interventions. Our analysis identified a brain-wide gene signature of aging in glial cells, which exhibited spatially defined changes in magnitude. By integrating spatial and single-nucleus transcriptomics, we found that glial aging was particularly accelerated in white matter compared with cortical regions, whereas specialized neuronal populations showed region-specific expression changes. Rejuvenation interventions, including young plasma injection and dietary restriction, exhibited distinct effects on gene expression in specific brain regions. Furthermore, we discovered differential gene expression patterns associated with three human neurodegenerative diseases, highlighting the importance of regional aging as a potential modulator of disease. Our findings identify molecular foci of brain aging, providing a foundation to target age-related cognitive decline.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37591239/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37591239</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2023.07.027>10.1016/j.cell.2023.07.027</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37591239</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Oliver Hahn</dc:creator>
<dc:creator>Aulden G Foltz</dc:creator>
<dc:creator>Micaiah Atkins</dc:creator>
<dc:creator>Blen Kedir</dc:creator>
<dc:creator>Patricia Moran-Losada</dc:creator>
<dc:creator>Ian H Guldner</dc:creator>
<dc:creator>Christy Munson</dc:creator>
<dc:creator>Fabian Kern</dc:creator>
<dc:creator>Róbert Pálovics</dc:creator>
<dc:creator>Nannan Lu</dc:creator>
<dc:creator>Hui Zhang</dc:creator>
<dc:creator>Achint Kaur</dc:creator>
<dc:creator>Jacob Hull</dc:creator>
<dc:creator>John R Huguenard</dc:creator>
<dc:creator>Sebastian Grönke</dc:creator>
<dc:creator>Benoit Lehallier</dc:creator>
<dc:creator>Linda Partridge</dc:creator>
<dc:creator>Andreas Keller</dc:creator>
<dc:creator>Tony Wyss-Coray</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Atlas of the aging mouse brain reveals white matter as vulnerable foci</dc:title>
<dc:identifier>pmid:37591239</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2023.07.027</dc:identifier>
</item>
<item>
<title>Histopathology of atrial fibrillation: does this help us understand its pathogenesis?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590445/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2023 Aug 17:ehad515. doi: 10.1093/eurheartj/ehad515. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590445/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37590445</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehad515>10.1093/eurheartj/ehad515</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590445</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Rika Kawakami</dc:creator>
<dc:creator>Aloke V Finn</dc:creator>
<dc:creator>Renu Virmani</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Histopathology of atrial fibrillation: does this help us understand its pathogenesis?</dc:title>
<dc:identifier>pmid:37590445</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehad515</dc:identifier>
</item>
<item>
<title>Danicamtiv Recruits Myosin Motors to Aid the Failing Heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590375/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18;133(5):444-446. doi: 10.1161/CIRCRESAHA.123.323366. Epub 2023 Aug 17.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590375/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37590375</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.123.323366>10.1161/CIRCRESAHA.123.323366</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590375</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Maicon Landim-Vieira</dc:creator>
<dc:creator>Bjorn C Knollmann</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Danicamtiv Recruits Myosin Motors to Aid the Failing Heart</dc:title>
<dc:identifier>pmid:37590375</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.123.323366</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37590374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 18;133(5):374-375. doi: 10.1161/RES.0000000000000629. Epub 2023 Aug 17.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37590374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37590374</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000629>10.1161/RES.0000000000000629</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37590374</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:37590374</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000629</dc:identifier>
</item>
<item>
<title>Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/37589160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20230820000919&amp;v=2.17.9.post6+86293ac
      <description>CONCLUSIONS: By maintaining endothelial mitochondrial homeostasis, deSUMOylation of FIS1 adaptively preserves pulmonary endothelial function against hypoxic stress and consequently protects against PH. The FIS1 deSUMOylation-SUMOylation transition in pulmonary endothelium is an intrinsic pathogenesis of hypoxic PH.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2023 Aug 17. doi: 10.1161/CIRCRESAHA.122.321200. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Hypoxia is a major cause and promoter of pulmonary hypertension (PH), a representative vascular remodeling disease with poor prognosis and high mortality. However, the mechanism underlying how pulmonary arterial system responds to hypoxic stress during PH remains unclear. Endothelial mitochondria are considered signaling organelles on oxygen tension. Results from previous clinical research and our studies suggested a potential role of posttranslational SUMOylation in endothelial mitochondria in hypoxia-related vasculopathy.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Chronic hypoxia mouse model and Sugen/hypoxia rat model were employed as PH animal models. Mitochondrial morphology and subcellular structure were determined by transmission electron and immunofluorescent microscopies. Mitochondrial metabolism was determined by mitochondrial oxygen consumption rate and extracellular acidification rate. SUMOylation and protein interaction were determined by immunoprecipitation.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: The involvement of SENP1 (sentrin-specific protease 1)-mediated SUMOylation in mitochondrial remodeling in the pulmonary endothelium was identified in clinical specimens of hypoxia-related PH and was verified in human pulmonary artery endothelial cells under hypoxia. Further analyses in clinical specimens, hypoxic rat and mouse PH models, and human pulmonary artery endothelial cells and human embryonic stem cell-derived endothelial cells revealed that short-term hypoxia-induced SENP1 translocation to endothelial mitochondria to regulate deSUMOylation of mitochondrial fission protein FIS1 (mitochondrial fission 1), which facilitated FIS1 assembling with fusion protein MFN2 (mitofusin 2) and mitochondrial gatekeeper VDAC1 (voltage-dependent anion channel 1), and the membrane tethering activity of MFN2 by enhancing its oligomerization. Consequently, FIS1 deSUMOylation maintained the mitochondrial integrity and endoplasmic reticulum-mitochondria calcium communication across mitochondrial-associated membranes, subsequently preserving pulmonary endothelial function and vascular homeostasis. In contrast, prolonged hypoxia disabled the FIS1 deSUMOylation by diminishing the availability of SENP1 in mitochondria via inducing miR-138 and consequently resulted in mitochondrial dysfunction and metabolic reprogramming in pulmonary endothelium. Functionally, introduction of viral-packaged deSUMOylated FIS1 within pulmonary endothelium in mice improved pulmonary endothelial dysfunction and hypoxic PH development, while knock-in of SUMO (small ubiquitin-like modifier)-conjugated FIS1 in mice exaggerated the diseased cellular and tissue phenotypes.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: By maintaining endothelial mitochondrial homeostasis, deSUMOylation of FIS1 adaptively preserves pulmonary endothelial function against hypoxic stress and consequently protects against PH. The FIS1 deSUMOylation-SUMOylation transition in pulmonary endothelium is an intrinsic pathogenesis of hypoxic PH.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/37589160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20230820000919&v=2.17.9.post6+86293ac">37589160</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.122.321200>10.1161/CIRCRESAHA.122.321200</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:37589160</guid>
<pubDate>Thu, 17 Aug 2023 06:00:00 -0400</pubDate>
<dc:creator>Xiaofei Zhou</dc:creator>
<dc:creator>Yuanqing Jiang</dc:creator>
<dc:creator>Yuewen Wang</dc:creator>
<dc:creator>Linge Fan</dc:creator>
<dc:creator>Yunhui Zhu</dc:creator>
<dc:creator>Yefeng Chen</dc:creator>
<dc:creator>Yiran Wang</dc:creator>
<dc:creator>Yingyi Zhu</dc:creator>
<dc:creator>Hongkun Wang</dc:creator>
<dc:creator>Zihang Pan</dc:creator>
<dc:creator>Zhoubin Li</dc:creator>
<dc:creator>Xiaolong Zhu</dc:creator>
<dc:creator>Ruizhe Ren</dc:creator>
<dc:creator>Zhen Ge</dc:creator>
<dc:creator>Dongwu Lai</dc:creator>
<dc:creator>En-Yin Lai</dc:creator>
<dc:creator>Ting Chen</dc:creator>
<dc:creator>Kai Wang</dc:creator>
<dc:creator>Ping Liang</dc:creator>
<dc:creator>Lingfeng Qin</dc:creator>
<dc:creator>Cuiqing Liu</dc:creator>
<dc:creator>Cong Qiu</dc:creator>
<dc:creator>Michael Simons</dc:creator>
<dc:creator>Luyang Yu</dc:creator>
<dc:date>2023-08-17</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Endothelial FIS1 DeSUMOylation Protects Against Hypoxic Pulmonary Hypertension</dc:title>
<dc:identifier>pmid:37589160</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.122.321200</dc:identifier>
</item>





























</channel>
</rss>